Clinical trial

Typical design features

Well-designed trials use predefined methods to reduce bias and increase reliability. Common features include:

• Randomization — allocating participants by chance to different groups.
• Control groups — comparing the investigational intervention with a standard treatment or a placebo control.
• Blinding — keeping participants, clinicians, or evaluators unaware of group assignment to prevent expectation effects.
• Endpoints — predefined outcomes that determine whether the intervention is effective or safe.

Phases and purpose

Clinical development is commonly described in phases: early phases focus on safety and dosing in small groups; later phases assess effectiveness and monitor adverse events in larger, more diverse populations. Postmarketing studies continue to monitor long-term safety and comparative effectiveness after approval.

Ethics, oversight and statistical considerations

Trials require informed consent, independent ethical review (institutional review boards or ethics committees), and regulatory authorization. Statistical planning—sample size, power, and analysis methods—must be set in advance because trials are inferential studies that use probability to decide whether observed differences are likely to be real rather than due to chance.

Uses and distinctions

Clinical trials are used in many areas, from vaccines and antibiotics to cancer therapies and medical devices. They differ from observational studies, which describe outcomes without assigning interventions. Transparent reporting, trial registration, and data monitoring boards help protect participants and improve the credibility of results.

Well-conducted clinical trials are central to evidence-based medicine: they inform guidelines, regulatory decisions, and clinical practice by providing systematic evidence about benefits, harms, and optimal use of interventions.